ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2016 American Transplant Congress

    Late Renal Xenograft Failure Is Antibody-Mediated: Description of the Longest-Reported Survival in Pig-to-Primate Renal Xenotransplantation.

    L. Higginbotham,1 S. Kim,1 D. Mathews,1 A. Stephenson,1 C. Breeden,1 C. Larsen,1 M. Ford,1 K. Newell,1 A. Tector,2 A. Adams.1

    1Emory Transplant Center, Emory University Hospital, Atlanta, GA; 2Indiana University School of Medicine, Indianapolis, IN.

    Introduction. Xenotransplantation has the potential to alleviate the organ supply shortage, yet pig-to-primate renal xenotransplant has met limited success due to natural preformed anti-pig antibody.…
  • 2016 American Transplant Congress

    IFN-γ and Contact-Dependent Cytotoxicity Are Rate-Limiting for NK Cells in a Model of Antibody-Mediated Chronic Rejection.

    C. Lin,1 R. Plenter,1 R. Gill.2

    1Medicine, University of Colorado, Denver, Aurora, CO; 2Surgery, University of Colorado, Denver, Aurora, CO.

    BACKGROUND. Natural killer (NK) cells are key components of the innate immune that contribute to acute and chronic graft rejection. After engagement with antibody, NK…
  • 2016 American Transplant Congress

    Ibrutinib Suppresses Alloantibody Responses in A Mouse Model of Allosensitization: A Preliminary Report.

    G. Wu, I. Kim, N.-N. Chai, A. Klein, S. Jordan.

    CTC/Surgery, Cedars-Sinai Medical Center, Los Angeles, CA.

    Background Ibrutinib is a Bruton tyrosine Kinase (BTK) antagonist that inhibits B cell receptor (BCR) signaling, therefore blocking B cell activation. Ibrutinib is approved by…
  • 2016 American Transplant Congress

    Renal Fibroblast Activation and Survival by Anti-MHC Class I Antibody: The Role of mTOR Signaling Pathway.

    J. Chen, A. Zmijewska, R. Mannon.

    Medicine/Surgery, University of Alabama at Birmingham, Birmingham, AL.

    Background: Antibody-mediated injury (AMI) is an important contributor to late kidney allograft loss, and is accompanied by interstitial fibrosis (IF) and tubular atrophy (TA). However,…
  • 2016 American Transplant Congress

    The Role of B Cells in Liver Transplant Tolerance.

    M. Morita,2 G. Enyindah-Asonye,1 N. Gupta,1 J. Fung,2 S. Qian,1,2 L. Lu.1,2

    1Immunology, LernerResearch Institute, Cleveland Clinic, Cleveland, OH; 2General Surgery, Transplant Center, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH.

    Scarcely one would argue that donor-specific B cells and antibodies contribute to rejection of transplants. However, studies published in the past few years have provided…
  • 2016 American Transplant Congress

    Recall Alloantibody Production Is Driven by CD138+ Cells Proliferating in the Spleens: An Indication for Long-Lived Plasma Cell Activities and Potential Therapeutic Target.

    I. Kim, N.-N. Chai, A. Klein, S. Jordan, G. Wu.

    Comprehensive Transplantation Center/Surgery, Cedars-Sinai Medical Center, Los Angeles, CA.

    Background Donor-specific antibodies (DSA) generated in recall responses are produced by long-lived plasma cells (L-PC) residing in the bone marrows (BM). Mechanisms of L-PC activation,…
  • 2016 American Transplant Congress

    Alloantibody Suppression by Bruton Tyrosine Kinase Antagonist Ibrutinib Is Associated with a Moderate Splenic B-Cell Reduction.

    N.-N. Chai, I. Kim, S. Jordan, A. Klein, G. Wu.

    Comprehensive Transplantation Center/Surgery, Cedars-Sinai Medical Center, Los Angeles, CA.

    Background Bruton tyrosine kinase (Btk) is specifically required for activation of the B-cell antigen receptor signaling pathway that contributes to the initiation and maintenance of…
  • 2016 American Transplant Congress

    The Role of HLA Class II Antibody in Endothelial Cell Activation and Allograft Rejection.

    G. Cantanhede,1 V. Carter,2 K. Giles,2 J. Kirby,1 S. Ali.1

    1Institute of Cellular Medicine, University of Newcastle, Newcastle, Tyne and Wear, United Kingdom; 2Histocompatibility and Immunogenetics, National Health Service Blood and Transplant, Newcastle, Tyne and Wear, United Kingdom.

    Background: Antibody-mediated rejection is one of the major causes of chronic rejection. This is mediated by endothelial cell activation, a process of endothelium microvascular inflammation…
  • 2016 American Transplant Congress

    Interaction Between Kidney Tissue Proteome and Humoral Immunity in Antibody Mediated Rejection.

    A. Konvalinka,1 A. Chruscinski,2 S. Kim,1 K. Tinckam,1 I. Jurisica,3 R. John.4

    1Medicine/Division of Nephrology, Toronto General Hospital, Toronto, ON, Canada; 2Medicine/Division of Cardiology, Toronto General Hospital, Toronto, ON, Canada; 3Medical Biophysics and Computational Science, University of Toronto, Toronto, ON, Canada; 4Pathology, Toronto General Hospital, Toronto, ON, Canada.

    PURPOSE: Antibody-mediated rejection (AMR) is caused by antibodies against human leukocyte antigens (HLA) on graft endothelium, and non-HLA antibodies that target endothelial and epithelial proteins.…
  • 2016 American Transplant Congress

    Impact of CXCR4/CXCL12 Blockade on Normal Plasma Cells In Vivo.

    K. Bonner, N. Moore, M. Moreno Gonzales, M. Stegall.

    Department of Surgery, Division of Transplant Surgery, Mayo Clinic, Rochester, MN.

    Introduction:Plasma cells (PCs) are a major source of alloantibody in transplant patients.They are resistant to current therapy. Since receptor/ligand interactions in the stromal environment are…
  • « Previous Page
  • 1
  • …
  • 1175
  • 1176
  • 1177
  • 1178
  • 1179
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences